Hyponatremia in the neurosurgical patient: Epidemiology, pathophysiology, diagnosis, and management

Neurosurgery

Volumn 59, Issue 2, 2006, Pages 222-228

  Fraser, Justin F ^a   Stieg, Philip E ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Arginine vasopressin receptor antagonists; Cerebral salt wasting; Hyponatremia; Subarachnoid hemorrhage; Syndrome of inappropriate antidiuretic hormone

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGIPRESSIN RECEPTOR; ARGIPRESSIN RECEPTOR ANTAGONIST; DOBUTAMINE; ELECTROLYTE; FLUDROCORTISONE; GLUCOCORTICOID; MINERALOCORTICOID; RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

BLOOD CLOTTING DISORDER; CENTRAL PONTINE MYELINOLYSIS; CLINICAL TRIAL; COMORBIDITY; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; FLUID BALANCE; HEART FAILURE; HUMAN; HYPONATREMIA; LUNG EDEMA; METABOLIC ACIDOSIS; NEUROSURGERY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

BRAIN DISEASES; COMORBIDITY; HUMANS; HYPONATREMIA; NATRIURETIC PEPTIDES; PREVALENCE; RECEPTORS, VASOPRESSIN; SODIUM; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 33748323169     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000223440.35642.6E     Document Type: Review

References (46)

1. Anderson RJ, Chung HM, Kluge R, Schrier RW: Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 102:164-168, 1985.
2. Bennani SL, Abouqal R, Zeggwagh AA, Madani N, Abidi K, Zekraoui A, Kerkeb O: Incidence, causes and prognostic factors of hyponatremia in intensive care [in French]. Rev Med Interne 24:224-229, 2003.
3. Berendes E, Walter M, Cullen P, Prien T, van Aken H, Horsthemke J, Schulte M, von Wild K, Scherer R: Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 349:245-249, 1997.
4. Berkenbosch JW, Lentz CW, Jimenez DF, Tobias JD: Cerebral salt wasting syndrome following brain injury in three pediatric patients: Suggestions for rapid diagnosis and therapy. Pediatr Neurosurg 36:75-79, 2002.
5. Dillingham MA, Anderson RJ: Inhibition of vasopressin action by atrial natriuretic factor. Science 231:1572-1573, 1986.
6. Fraser CL, Arieff AI: Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med 102:67-77, 1997.
7. Fukui S, Nawashiro H, Otani N, Ooigawa H, Toyooka T, Tsuzuki N, Katoh H, Ishihara S, Miyazawa T, Ohnuki A, Shima K: Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage. Acta Neurochir Suppl 86:489-491, 2003.
8. Harrigan MR: Cerebral salt wasting syndrome: A review. Neurosurgery 38:152-160, 1996.
9. Harris PJ, Thomas D, Morgan TO: Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 326:697-698, 1987.
10. Hasan D, Wijdicks EF, Vermeulen M: Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol 27:106-108, 1990.
11. Juul R, Edvinsson L, Ekman R, Frederiksen TA, Unsgard G, Gisvold SE: Atrial natriuretic peptide-LI following subarachnoid haemorrhage in man. Acta Neurochir (Wien) 106:18-23, 1990.
12. Ke C, Poon WS, Ng HK, Tang NL, Chan Y, Wang JY, Hsiang JN: The impact of acute hyponatraemia on severe traumatic brain injury in rats. Acta Neurochir Suppl 76:405-408, 2000.
13. Kojima J, Katayama Y, Moro N, Kawai H, Yoneko M, Mori T: Cerebral salt wasting in subarachnoid hemorrhage rats: Model, mechanism, and tool. Life Sci 76:2361-2370, 2005.
14. Laszlo FA, Varga C, Nakamura S: Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage. Eur J Pharmacol 364:115-122, 1999.
15. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 339:321-328, 1998.
16. Levin ER, Hu RM, Rossi M, Pickart M: Arginine vasopressin stimulates atrial natriuretic peptide gene expression and secretion from rat diencephalic neurons. Endocrinology 131:1417-1423, 1992.
17. McGirt MJ, Blessing R, Nimjee SM, Friedman AH, Alexander MJ, Laskowitz DT, Lynch JR: Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 54:1369-1373, 2004.
18. Mori T, Katayama Y, Kawamata T, Hirayama T: Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 91:947-952, 1999.
19. Mulloy AL, Caruana RJ: Hyponatremic emergencies. Med Clin N Am 79:155-168, 1995.
20. Naito A, Hasegawa H, Kurasawa T, Ohtake Y, Matsukawa H, Ezure Y, Tsuriya Y, Koike K, Shigenobu K: The therapeutic efficacy of VP-343, a selective vasopressin V2 receptor antagonist, in the experimental SIADH rat model. Biol Pharm Bull 23:1323-1327, 2000.
21. Palm C, Reimann D, Gross P: The role of V2 vasopressin antagonists in hyponatremia. Cardiovasc Res 51:403-408, 2001.
22. Palmer BF: Hyponatraemia in a neurosurgical patient: Syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant 15:262-268, 2000.
23. Patwari AK, Singh BS, Manorama DE: Inappropriate secretion of antidiuretic hormone in acute bacterial meningitis. Ann Trop Paediatr 15:179-183, 1995.
24. Qureshi AI, Suri MF, Sung GY, Straw RN, Yahia AM, Saad M, Guterman LR, Hopkins LN: Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 50:749-755, 2002.
25. Rabinstein AA, Wijdicks EF: Hyponatremia in critically ill neurological patients. Neurologist 9:290-300, 2003.
26. Roca-Ribas F, Ninno JE, Gasperin A, Lucas M, Llubia C: Cerebral salt wasting syndrome as a postoperative complication after surgical resection of acoustic neuroma. Otol Neurotol 23:992-995, 2002.
27. Rosenberg GA, Scremin O, Estrada E, Kyner WT: Arginine vasopressin V1-antagonist and atrial natriuretic peptide reduce hemorrhagic brain edema in rats. Stroke 23:1767-1773, 1992.
28. Saito T, Ishikawa S, Abe K, Kamoi K, Yamada K, Shimizu K, Saruta T, Yoshida S: Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Clin Endocrinol Metab 82:1054-1057, 1997.
29. Sakarcan A, Bocchini J Jr: The role of fludrocortisone in a child with cerebral salt wasting. Pediatr Nephrol 12:769-771, 1998.
30. Sayama T, Inamura T, Matsushima T, Inoha S, Inoue T, Fukui M: High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms. Neurol Res 22:151-155, 2000.
31. Serradeil-Le Gal C, Lacour C, Valette G, Garcia G, Foulon L, Galindo G, Bankir L, Pouzet B, Guillon G, Barberis C, Chicot D, Jard S, Vilain P, Garcia C, Marty E, Raufaste D, Brossard G, Nisato D, Maffrand JP, le Fur G: Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest 98:2729-2738, 1996.
32. Shann F, Germer S: Hyponatraemia associated with pneumonia or bacterial meningitis. Arch Dis Child 60:963-966, 1985.
33. Smith DM, McKenna K, Thompson CJ: Hyponatraemia. Clin Endocrinol (Oxf) 52:667-678, 2000.
34. Sonnenberg H, Honrath U, Chong CK, Wilson DR: Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 250:F963-F966, 1986.
35. Suarez JI, Qureshi AI, Parekh PD, Razumovsky A, Tamargo RJ, Bhardwaj A, Ulatowski JA: Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol 11:178-184, 1999.
36. Sviri GE, Shik V, Raz B, Soustiel JF: Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir (Wien) 145:851-860, 2003.
37. Tang WH, Bhavnani S, Francis GS: Vasopressin receptor antagonists in the management of acute heart failure. Expert Opin Investig Drugs 14:593-600, 2005.
38. Trandafir CC, Nishihashi T, Wang A, Murakami S, Ji X, Kurahashi K: Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clin Exp Pharmacol Physiol 31:261-266, 2004.
39. Unterberg A, Kiening K, Schmiedek P, Lanksch W: Long-term observations of intracranial pressure after severe head injury: The phenomenon of secondary rise of intracranial pressure. Neurosurgery 32:17-23, 1993.
40. van de Beek D, de Gans J, Spanjaard L, Sela S, Vermeulen M, Dankert J: Group a streptococcal meningitis in adults: Report of 41 cases and a review of the literature. Clin Infect Dis 34:e32-e36, 2002.
41. Wei T, Zuyuan R, Changbao S, Renzhi W, Yi Y, Wenbin M: Hyponatremia after transspheniodal surgery of pituitary adenoma. Chin Med Sci J 18:120-123, 2003.
42. Wijdicks EF, Ropper AH, Hunnicutt EJ, Richardson GS, Nathanson JA: Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage. Stroke 22:1519-1524, 1991.
43. Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J: Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: Is fluid restriction harmful? Ann Neurol 17:137-140, 1985.
44. Wijdicks EF, Vermeulen M, van Brummelen P, van Gijn J: The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 90:209-214, 1988.
45. Wijeyaratne CN, Moult PJ: The effect of alpha human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjects. J Clin Endocrinol Metab 76:343-346, 1993.
46. Yamamura Y, Ogawa H, Yamashita H, Chihara T, Miyamoto H, Nakamura S, Onogawa T, Yamashita T, Hosokawa T, Mori T, Tominaga M, Yabuuchi Y: Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol 105:787-791, 1992.